Skip to main content
. Author manuscript; available in PMC: 2014 Dec 30.
Published in final edited form as: Biochem Pharmacol. 2008 Feb 29;75(11):2147–2156. doi: 10.1016/j.bcp.2008.02.027

Fig. 1.

Fig. 1

Effects of siRNA3 target on mRNA and protein levels of RyR2 in rat primary cardiomyocytes with transfection after 6–72 h tested by RT-PCR and western blot. (A) Changes in mRNA levels of RyR2 in cardiomyocytes with siRNA3 transfection after 6–72 h. GAPDH served as an internal control for analysis of the PCR productions. (B) Changes in protein expressions of RyR2 in cardiomyocytes with siRNA3 transfection after 6–72 h. β-Actin was used as a standard for analysis of the protein samples. Data are presented as the mean ± S.E. Differences were considered statistically significant when p-value <0.05, t-test, n = 4.